Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
BMRN
BMRN News & Events
-
Add to Watchlist
Trade BMRN
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
BMRN News
BioMarin to Host Q4 2025 Earnings Call on February 23, 2026
2d ago
PRnewswire
Phenylketonuria Treatment Market Outlook Analysis
1d ago
Newsfilter
BridgeBio Pharma Stock Soars on Positive Clinical Trial Results
Feb 12 2026
Benzinga
BioMarin Pharmaceutical Stock Outlook Looks Promising
Feb 08 2026
Yahoo Finance
BioMarin Pharmaceutical Set to Report 2025 Financial Results Soon
Jan 31 2026
Fool
BioMarin Expects Strong Sales for Voxzogo in Q4
Jan 31 2026
NASDAQ.COM
FDA Approves Zycubo for Pediatric Menkes Disease Treatment
Jan 28 2026
NASDAQ.COM
BioMarin Plans $850M Senior Unsecured Notes Offering
Jan 26 2026
seekingalpha
Show More News
BMRN Events
No data
BMRN Monitor News
BioMarin to Host Q4 2025 Earnings Call on February 23, 2026
Feb 19 2026
BioMarin to Host Q4 2025 Earnings Call on February 23, 2026
Feb 18 2026
BioMarin to acquire Amicus for $4.8 billion
Dec 19 2025
BMRN Earnings Analysis
BioMarin 2025 Earnings: Accelerated Growth Insights- Intellectia AI™
3 months ago
BioMarin Earnings: 2024 Strength Fuels 2025 Growth- Intellectia AI™
1 years ago
BioMarin Pharmaceutical Inc Announces Third Quarter 2024 Financial Results
1 years ago
People Also Watch
